![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Fbxo33 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Fbxo33 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FBXO33 mRNA | CTD | PMID:36331819 | Fbxo33 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of FBXO33 mRNA | CTD | PMID:22206623 | Fbxo33 | Rat | 17beta-estradiol | increases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | Estradiol results in increased expression of FBXO33 mRNA | CTD | PMID:19484750 | Fbxo33 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FBXO33 mRNA | CTD | PMID:31826744 | Fbxo33 | Rat | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | 2,3',4,4',5-pentachlorobiphenyl results in increased expression of FBXO33 mRNA | CTD | PMID:31388691 | Fbxo33 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Fbxo33 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FBXO33 mRNA | CTD | PMID:21570461 | Fbxo33 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FBXO33 mRNA | CTD | PMID:33387578 | Fbxo33 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | bisphenol S results in increased expression of FBXO33 mRNA | CTD | PMID:39298647 | Fbxo33 | Rat | atrazine | increases expression | ISO | FBXO33 (Homo sapiens) | 6480464 | Atrazine results in increased expression of FBXO33 mRNA | CTD | PMID:22378314 | Fbxo33 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of FBXO33 gene | CTD | PMID:35440735 | Fbxo33 | Rat | Benoxacor | increases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | benoxacor results in increased expression of FBXO33 mRNA | CTD | PMID:34850242 | Fbxo33 | Rat | benzo[a]pyrene | increases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of FBXO33 mRNA | CTD | PMID:22228805 | Fbxo33 | Rat | benzo[a]pyrene | affects methylation | ISO | FBXO33 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of FBXO33 promoter | CTD | PMID:27901495 | Fbxo33 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of FBXO33 mRNA | CTD | PMID:21318169 | Fbxo33 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FBXO33 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:32528016 | Fbxo33 | Rat | bisphenol A | increases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | bisphenol A results in increased expression of FBXO33 mRNA | CTD | PMID:33221593 | Fbxo33 | Rat | cadmium atom | multiple interactions | ISO | FBXO33 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXO33 more ... | CTD | PMID:35301059 | Fbxo33 | Rat | cadmium dichloride | multiple interactions | ISO | FBXO33 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXO33 more ... | CTD | PMID:35301059 | Fbxo33 | Rat | chlordecone | increases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | Chlordecone results in increased expression of FBXO33 mRNA | CTD | PMID:33711761 | Fbxo33 | Rat | clothianidin | decreases expression | ISO | FBXO33 (Homo sapiens) | 6480464 | clothianidin results in decreased expression of FBXO33 mRNA | CTD | PMID:31626844 | Fbxo33 | Rat | Dibutyl phosphate | affects expression | ISO | FBXO33 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of FBXO33 mRNA | CTD | PMID:37042841 | Fbxo33 | Rat | dibutyl phthalate | increases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of FBXO33 mRNA | CTD | PMID:21266533 | Fbxo33 | Rat | diclofenac | increases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | Diclofenac results in increased expression of FBXO33 mRNA | CTD | PMID:35537566 | Fbxo33 | Rat | dicrotophos | decreases expression | ISO | FBXO33 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of FBXO33 mRNA | CTD | PMID:28302478 | Fbxo33 | Rat | ethanol | affects splicing | ISO | Fbxo33 (Mus musculus) | 6480464 | Ethanol affects the splicing of FBXO33 mRNA | CTD | PMID:30319688 | Fbxo33 | Rat | fluoranthene | multiple interactions | ISO | Fbxo33 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of FBXO33 mRNA | CTD | PMID:28329830 | Fbxo33 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of FBXO33 mRNA | CTD | PMID:33387578 | Fbxo33 | Rat | GSK-J4 | increases expression | ISO | FBXO33 (Homo sapiens) | 6480464 | GSK-J4 results in increased expression of FBXO33 mRNA | CTD | PMID:29301935 | Fbxo33 | Rat | inulin | multiple interactions | ISO | Fbxo33 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FBXO33 mRNA | CTD | PMID:36331819 | Fbxo33 | Rat | lead diacetate | increases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | lead acetate results in increased expression of FBXO33 mRNA | CTD | PMID:21829687 | Fbxo33 | Rat | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of FBXO33 mRNA | CTD | PMID:19564919 | Fbxo33 | Rat | okadaic acid | increases expression | ISO | FBXO33 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of FBXO33 mRNA | CTD | PMID:38832940 | Fbxo33 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of FBXO33 mRNA | CTD | PMID:25729387 | Fbxo33 | Rat | ozone | multiple interactions | ISO | FBXO33 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of FBXO33 mRNA | CTD | PMID:35430440 | Fbxo33 | Rat | p-toluidine | decreases expression | EXP | | 6480464 | 4-toluidine results in decreased expression of FBXO33 mRNA | CTD | PMID:27638505 | Fbxo33 | Rat | paracetamol | increases expression | ISO | FBXO33 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of FBXO33 mRNA | CTD | PMID:21420995 | Fbxo33 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of FBXO33 mRNA | CTD | PMID:33387578 | Fbxo33 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Fbxo33 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FBXO33 mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Fbxo33 | Rat | phenobarbital | affects expression | ISO | Fbxo33 (Mus musculus) | 6480464 | Phenobarbital affects the expression of FBXO33 mRNA | CTD | PMID:23091169 | Fbxo33 | Rat | pirinixic acid | multiple interactions | ISO | Fbxo33 (Mus musculus) | 6480464 | PPARA protein affects the reaction [pirinixic acid results in decreased expression of FBXO33 mRNA] | CTD | PMID:21318169 | Fbxo33 | Rat | pirinixic acid | decreases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of FBXO33 mRNA | CTD | PMID:21318169 | Fbxo33 | Rat | potassium chloride | multiple interactions | ISO | FBXO33 (Homo sapiens) | 6480464 | [Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of FBXO33 more ... | CTD | PMID:29691375 | Fbxo33 | Rat | silver atom | decreases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | Silver results in decreased expression of FBXO33 mRNA | CTD | PMID:27131904 | Fbxo33 | Rat | silver(0) | decreases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | Silver results in decreased expression of FBXO33 mRNA | CTD | PMID:27131904 | Fbxo33 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of FBXO33 mRNA | CTD | PMID:19281266 | Fbxo33 | Rat | sunitinib | increases expression | ISO | FBXO33 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of FBXO33 mRNA | CTD | PMID:31533062 | Fbxo33 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of FBXO33 mRNA | CTD | PMID:34492290 | Fbxo33 | Rat | thiram | increases expression | ISO | FBXO33 (Homo sapiens) | 6480464 | Thiram results in increased expression of FBXO33 mRNA | CTD | PMID:38568856 | Fbxo33 | Rat | titanium dioxide | decreases methylation | ISO | Fbxo33 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of FBXO33 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Fbxo33 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of FBXO33 mRNA | CTD | PMID:25729387 | Fbxo33 | Rat | trichloroethene | affects expression | ISO | Fbxo33 (Mus musculus) | 6480464 | Trichloroethylene affects the expression of FBXO33 mRNA | CTD | PMID:21135412 | Fbxo33 | Rat | trichostatin A | affects expression | ISO | FBXO33 (Homo sapiens) | 6480464 | trichostatin A affects the expression of FBXO33 mRNA | CTD | PMID:28542535 | Fbxo33 | Rat | triphenyl phosphate | affects expression | ISO | FBXO33 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of FBXO33 mRNA | CTD | PMID:37042841 | Fbxo33 | Rat | triptonide | increases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | triptonide results in increased expression of FBXO33 mRNA | CTD | PMID:33045310 | Fbxo33 | Rat | trovafloxacin | increases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | trovafloxacin results in increased expression of FBXO33 mRNA | CTD | PMID:35537566 | Fbxo33 | Rat | tungsten | increases expression | ISO | Fbxo33 (Mus musculus) | 6480464 | Tungsten results in increased expression of FBXO33 mRNA | CTD | PMID:30912803 | Fbxo33 | Rat | urethane | increases expression | ISO | FBXO33 (Homo sapiens) | 6480464 | Urethane results in increased expression of FBXO33 mRNA | CTD | PMID:28818685 | Fbxo33 | Rat | valproic acid | affects expression | ISO | FBXO33 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of FBXO33 mRNA | CTD | PMID:25979313 | Fbxo33 | Rat | valproic acid | increases expression | ISO | FBXO33 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of FBXO33 mRNA | CTD | PMID:29154799 | Fbxo33 | Rat | valproic acid | decreases methylation | ISO | FBXO33 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of FBXO33 gene | CTD | PMID:29154799 | Fbxo33 | Rat | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of FBXO33 mRNA | CTD | PMID:22570695 | Fbxo33 | Rat | vincristine | decreases expression | ISO | FBXO33 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of FBXO33 mRNA | CTD | PMID:23649840 | Fbxo33 | Rat | zinc atom | multiple interactions | ISO | FBXO33 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of FBXO33 mRNA | CTD | PMID:18593933 | Fbxo33 | Rat | zinc(0) | multiple interactions | ISO | FBXO33 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of FBXO33 mRNA | CTD | PMID:18593933 | |